MiR-107 and Its Association With House Dust Mite Sensitisation: Implications for Asthma

Byung-Keun Kim1,2, Min-Suk Yang1,3, Upasna Srivastava1,4

  • 1Division of Pediatric Respiratory Medicine, Department of Pediatrics, University of California San Diego, La Jolla, California, USA.

Abstract

Insights

MicroRNA-107 (miR-107) is linked to house dust mite sensitization in children with asthma. This sensitization indirectly affects total IgE and eosinophil counts via miR-107.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • MicroRNAs (miRNAs) play a role in allergic diseases.
  • The impact of miRNAs on allergen sensitization in pediatric asthma remains unclear.

Purpose of the Study:

  • Identify specific miRNAs associated with house dust mite (HDM) sensitization in children diagnosed with asthma.
  • Investigate the relationship between identified miRNAs and clinical asthma phenotypes.

Main Methods:

  • Serum samples from 1126 children with asthma in the Genetics of Asthma in Costa Rica Study (GACRS) were analyzed for 304 miRNAs.
  • Differential expression analysis was performed between HDM-sensitized and non-sensitized groups, followed by gene enrichment analysis.
  • Replication analysis was conducted in the Childhood Asthma Management Program (CAMP) cohort, and mediation analysis explored miRNA-phenotype relationships.

Main Results:

  • 17 miRNAs were differentially expressed between HDM-sensitized and non-sensitized children in GACRS, with miR-107, let-7c-5p, and miR-642a-3p being most significant.
  • miR-107 expression was significantly increased in HDM-sensitized children and replicated in the CAMP cohort.
  • Mediation analysis revealed that miR-107 had indirect effects on eosinophil count and total IgE, mediated by HDM sensitization.

Conclusions:

  • miR-107 is significantly associated with HDM sensitization in pediatric asthma.
  • miR-107 acts as an indirect mediator linking HDM sensitization to elevated total IgE and eosinophil counts.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
240
Allergic Reactions02:06

Allergic Reactions

Overview
27.2K
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
247